TABLE 1

Cohort summarya

Patient
identifierb
Age
(yr)
Antibiotic
treatment
Episode
no.
MLST
ST
UropathogenResistance
GENMINNITSAMFEPCAZATMCROCFZAMPCIPSXTDOX
137Ertapenem1405E. coliRSSRRRRRRRRRI
266Ciprofloxacin112E. coliSSSRSRSRRRSSR
342Nitrofurantoin1551K. pneumoniaeSSSRSIIRRRRRR
462Nitrofurantoin1131E. coliSSSSSSRRRRSR
2E. coli
554Nitrofurantoin1131E. coliSSSSRRRRRRRSI
269E. coliSSSSSSRSS
643Nitrofurantoin1131E. coliRSSRRIIRRRRSI
2E. coli
872Meropenem1131E. coliSSSRRRRRRRRRR
988Doxycycline1131E. coliSSSIRRRRRRRRS
10c66Ertapenem1131E. coliSSSRRRRRRRRRR
1P. mirabilisRRRRISSRRRRRR
1362Nitrofurantoin1131E. coliSSSRRRRRRRRRR
2131E. coliSSSRRRRRRRRRR
3131E. coliSSSRRRRRRRRRR
1467Meropenem1P. mirabilisSRRSISSRRRRRR
2P. mirabilisSRRRISSRRRRRR
1564Ciprofloxacin,
co-trimoxazole
1131E. coliSSSSSSSSIRRSS
1674Ciprofloxacin,
nitrofurantoin
1131E. coliSSSIRRRRRRRRS
2E. coli
1843Cefalexin1131E. coliRSSSSSSSIRRRR
2131E. coliRSSISSSSRRRRR
  • a Abbreviations and symbols: GEN, gentamicin; MIN, minocycline; NIT, nitrofurantoin; SAM, ampicillin-sulbactam; FEP, cefepime; CAZ, ceftazidime; ATM, aztreonam; CRO, ceftriaxone; CFZ, cefazolin; AMP, ampicillin; CIP, ciprofloxacin; SXT, trimethoprim-sulfamethoxazole; DOX, doxycycline; R, resistant, S, susceptible; I, intermediate; —, missing data for isolates unavailable for analysis.

  • b All patients were female.

  • c Patient 10 received a kidney transplant.